Skip to main content

Table 5 Disease outcome following IMRT in selected published series including the own study

From: IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients

Authors HNC cohorts N patients LC (%) NC (%) LRC DC (%) OAS (%) time point
Eisbruch et al [11] oro/hypo/OC 133    94/77/60    3y
Dawson et al [1] HNC w/o NPC 58    79    2y
Own study HNC w/o NPC 115 77 87   78 86 2y
Eisbruch et al [11] dIMRT/pIMRT 60/73    81/84    3y
Chao et al [4] dIMRT/pIMRT 31/43    78/95 84/94 87 3y
Chao et al [5] dIMRT/pIMRT 52/74    79/90    2y
own study dIMRT/pIMRT 80/34 81/91 86/97   92/88 75/79 2y
Eisbruch et al [11] oro 80    94    3y
Garden et al [in 6] oro 80 (T1-2N0)    94    2y
De Arruda 17 oro 50 98 88   84 98 2y
Huang et al [in 6] oro 41 94   89 91 89 2y
Own study oro 56 88 93   93 87 2y
  1. LC local control; NC nodal control; LRC loco-regional control; DC distant control, OAS overall survival; oro oropharyngeal tumor; OC oral cavity tumor; NPC nasopharyngeal cancer; d/pIMRT defintive/postoperative IMRT.